Total Payments
$4,558
2024 Payments
$251.25
Companies
42
Transactions
135
Medicare Patients
1,861
Medicare Billing
$829,703
Payment Breakdown by Category
Food & Beverage$3,920 (86.0%)
Education$637.94 (14.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,920 | 128 | 86.0% |
| Education | $637.94 | 7 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $500.62 | 5 | $0 (2022) |
| Exelixis Inc. | $476.84 | 2 | $0 (2023) |
| Lilly USA, LLC | $309.22 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $280.99 | 6 | $0 (2023) |
| Genentech USA, Inc. | $269.99 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $250.62 | 15 | $0 (2024) |
| GENZYME CORPORATION | $213.11 | 6 | $0 (2023) |
| Incyte Corporation | $205.16 | 7 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $176.00 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $164.94 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.25 | 8 | Medtronic, Inc. ($115.38) |
| 2023 | $2,065 | 88 | Exelixis Inc. ($360.47) |
| 2022 | $646.01 | 15 | Lilly USA, LLC ($138.60) |
| 2021 | $688.89 | 12 | Lilly USA, LLC ($147.29) |
| 2020 | $177.48 | 3 | Janssen Biotech, Inc. ($99.00) |
| 2019 | $445.87 | 5 | Alexion Pharmaceuticals, Inc. ($176.00) |
| 2018 | $100.35 | 2 | E.R. Squibb & Sons, L.L.C. ($80.57) |
| 2017 | $183.39 | 2 | E.R. Squibb & Sons, L.L.C. ($183.39) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Genentech USA, Inc. | Columvi (Biological), Polivy | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: BioOncology | ||||||
| 09/23/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $115.38 | General |
| Category: Surgical Stapling | ||||||
| 07/21/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Oncology | ||||||
| 07/18/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Oncology | ||||||
| 07/18/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Oncology | ||||||
| 05/13/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ONCOLOGY | ||||||
| 12/22/2023 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: BioOncology | ||||||
| 12/20/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $360.47 | General |
| Category: Oncology | ||||||
| 12/19/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.63 | General |
| 12/15/2023 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Oncology | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Oncology | ||||||
| 12/11/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $21.34 | General |
| 12/07/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.36 | General |
| 12/06/2023 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Hematology | ||||||
| 12/05/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/01/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: ONCOLOGY | ||||||
| 11/28/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Oncology | ||||||
| 11/27/2023 | Genentech USA, Inc. | Alecensa (Biological), Tecentriq | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: BioOncology | ||||||
| 11/22/2023 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2023 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Hematology | ||||||
| 11/21/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 1,681 | 64,867 | $1.6M | $802,675 |
| 2022 | 9 | 180 | 239 | $47,560 | $27,028 |
Total Patients
1,861
Total Services
65,106
Medicare Billing
$829,703
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 13 | 14,200 | $960,000 | $555,706 | 57.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 3,060 | $76,500 | $57,052 | 74.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 278 | $48,650 | $27,992 | 57.5% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 13 | 348 | $112,800 | $25,457 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 163 | $36,675 | $23,290 | 63.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 55 | 220 | $66,000 | $22,904 | 34.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 111 | 121 | $33,275 | $16,836 | 50.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 172 | $25,800 | $16,601 | 64.3% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 37 | 28,050 | $56,100 | $11,237 | 20.0% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 14 | 44 | $19,800 | $5,598 | 28.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 45 | 308 | $15,400 | $3,796 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 217 | 431 | $4,310 | $3,605 | 83.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 43 | 69 | $10,350 | $3,526 | 34.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 53 | $5,300 | $3,392 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 42 | $5,250 | $2,925 | 55.7% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 19 | 53 | $6,625 | $2,723 | 41.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 158 | 331 | $8,275 | $2,519 | 30.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 163 | $6,520 | $1,816 | 27.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 21 | 77 | $5,775 | $1,736 | 30.1% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 21 | 60 | $6,000 | $1,505 | 25.1% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 11 | 34 | $4,250 | $1,504 | 35.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 47 | 57 | $2,850 | $1,476 | 51.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 14 | $2,800 | $1,300 | 46.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,200 | $1,166 | 53.0% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 30 | 114 | $3,990 | $1,148 | 28.8% |
About Dr. Laura Kohler, DO
Dr. Laura Kohler, DO is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679933956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Kohler, DO has received a total of $4,558 in payments from pharmaceutical and medical device companies, with $251.25 received in 2024. These payments were reported across 135 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,920).
As a Medicare-enrolled provider, Kohler has provided services to 1,861 Medicare beneficiaries, totaling 65,106 services with total Medicare billing of $829,703. Data is available for 2 years (2022–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Sterling Heights, MI
- Active Since 03/01/2016
- Last Updated 10/24/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679933956
Products in Payments
- CABOMETYX (Drug) $476.84
- ELIQUIS (Drug) $386.10
- JEVTANA (Drug) $270.34
- IMBRUVICA (Drug) $222.32
- SOLIRIS (Drug) $176.00
- Kadcyla (Biological) $156.94
- DUPIXENT (Biological) $130.02
- SIGNIA (Device) $115.38
- OPDIVO (Biological) $114.52
- BRUKINSA (Drug) $102.37
- VERZENIO (Drug) $92.63
- Nubeqa (Drug) $90.16
- KISQALI (Drug) $85.74
- JAKAFI (Drug) $71.59
- Stivarga (Drug) $70.34
- Doptelet (Drug) $59.19
- Lenvima (Drug) $58.38
- Blincyto (Biological) $54.82
- Epkinly (Drug) $54.40
- LONSURF (Drug) $52.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Internal Medicine $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Internal Medicine $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Internal Medicine $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Internal Medicine $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Internal Medicine $12,259
Dr. Nicolas Marsheh, M.d, M.D
Internal Medicine — Payments: $10,498
Internal Medicine $10,498